The latest price of Japan’s Chloroaniline Carbamate Tablets in 2025 published on the entire Internet

Chloraniline carbamate tablets are a central skeletal muscle relaxant, developed and produced by Sawai Pharmaceutical Co., Ltd., Japan. The 125 mg drug strength was approved for marketing in Japan in October 1987. The 250mg specification was launched in July 1988 to further meet the needs of different dosages. This article will introduce in detail the latest price, medication guide, side effects and treatment measures of Japan's Chloroaniline Carbamate Tablets in 2025 announced on the Internet.

The latest price of Japan's chlorphenesin carbamate tablets in 2025 announced on the entire network

International market price

Japan's SAWAI Chlorphenesin Carbamate Tablets (SAWAI Chlorphenesin Carbamate Tablets) are produced by Japan's Sawai Pharmaceuticals. The specification is 250mg*100 tablets/box and the price is approximately US$16 per box. This price is applicable to international markets and provides a reference for patients who need this medicine.

Factors affecting price

Drug prices may be affected by a variety of factors, including exchange rate fluctuations, logistics costs, and supply conditions. Therefore, understanding the latest market quotes and comparing price differences between different suppliers before buying can help make the best choice.

Japanese Chloraniline Carbamate Tablets Medication Guide

Indications, Usage and Dosage

Japanese Chloraniline Carbamate Tablets is a central skeletal muscle relaxant, suitable for the treatment of painful spasms caused by motor system disorders. Adults usually take 250 mg orally or two 125 mg tablets three times a day after meals. The specific dose should be appropriately adjusted based on the patient's gender, age, and severity of symptoms.

Recommendations for use in special populations

For the elderly, children and those with liver and kidney dysfunction, further reduction in dosage and close monitoring may be required. Pregnant or lactating women should use caution after weighing the benefits and potential risks of treatment before use. Specific guidance has not yet been provided for men and women of reproductive potential.

Side effects and treatment measures of Japan's Chloroaniline Carbamate Tablets

Common side effects

Drowsiness, decreased concentration and other side effects may occur while taking Japan's Chloroaniline Carbamate Tablets. More serious conditions such as bone marrow suppression or toxic epidermal necrolysis (TEN) are uncommon but are also risky. Symptoms such as headache, fatigue, and fatigue may also occur in the mental and nervous system; abdominal pain, nausea, diarrhea, etc. may occur in the digestive system.

Countermeasures

Once you notice any abnormal symptoms, you should stop taking the medication immediately and seek medical help. Long-term users should undergo regular blood, urine and liver function monitoring. In addition, you should avoid driving and operating dangerous machinery while taking the drug to prevent accidents caused by drowsiness or decreased concentration.